Asia · Markets & Finance · The Edge Singapore

Novartis inks Chinese mRNA-therapy deal for up to US$7.8 bil

Published by The Edge Singapore · Singapore 8 h ago

Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as US$7.8 billion.

Read the full article on The Edge Singapore Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.theedgesingapore.com)

Also worth reading

The Economic Times

CJP warns of Jantar Mantar 2.0 after Mumbai protest

Granules India incorporates wholly owned subsidiary in Brazil

The Business Times

G7 to release 100 million barrels of diesel and other reserves as prices soar

Sumeet Bagadia's top 3 stocks to buy: HDFC Life, Cummins India, CG Power | Target, stoploss, Nifty, Bank Nifty outlook

The Straits Times Business

Tesla posts stronger-than-expected quarterly deliveries

Business Standard

Cheaper, fresh-issue IPOs deliver stronger gains for investors who hold on